Status:

COMPLETED

Progesterone Variation on the Final Day of Oocyte Maturation.

Lead Sponsor:

Fundacion Dexeus

Conditions:

Controlled Ovarian Stimulation

Progesterone Variation on Trigger Day

Eligibility:

FEMALE

18-35 years

Brief Summary

The current study, aims through a robust design to provide a simple answer on whether progesterone levels of the same individual may significantly vary depending on the time of blood retrieval before ...

Eligibility Criteria

Inclusion

  • Healthy oocyte donors according to spanish law for oocyte donation
  • Controlled ovarian stimulation following a flexible antagonist protocol and stimulation with recombinant Follicular stimulating hormone.
  • Informed consent signed

Exclusion

  • Detection of luteinizing hormone surge before triggering

Key Trial Info

Start Date :

November 1 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 25 2018

Estimated Enrollment :

22 Patients enrolled

Trial Details

Trial ID

NCT03366025

Start Date

November 1 2017

End Date

January 25 2018

Last Update

April 4 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Salud de la Mujer Dexeus

Barcelona, Spain, 08028